Business Den's Kailyn Lamb reported today that the SEC filed a lawsuit on March 5th against Jeffrey Friedland, an advisor to Israel-based OWC Pharmaceuticals (OTC: OWCP), alleging fraud. The 36-page lawsuit demands that Friedland return nearly $7 million in gains from the sale of shares in the ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment